Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/13/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Donald R. Marvin

Wrong Donald R. Marvin?

President and Chief Executive Off...

Local Address: Montreal, Quebec, Canada
Inocucor Technologies Inc
7220 Frederick-Banting Suite 100
Montréal , Quebec H4S 2A1
Canada

Company Description: At Inocucor Technologies, Inc. we are dedicated to developing, manufacturing and marketing breakthrough products for the phyto-microbiome. We are currently seeking...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A.
    Iona College
  • B.S. degree
    Ohio State University
  • B.S.
    Ohio State University
  • M.B.A.
    Iona College.Send
174 Total References
Web References
Inocucor's President and CEO ...
www.agrimarketing.com, 13 Mar 2015 [cached]
Inocucor's President and CEO Donald R. Marvin said the new positions were created to meet increased demand for Inocucor's Garden Solution®, the company's first product, a biological accelerator used by greenhouse growers, mainstream production farmers and organic farmers.
"Biological solutions such as Inocucor's are in demand because they naturally increase yields, shorten time to harvest and improve soils," said Marvin. "We will continue to add high-caliber sales and technical staff to meet the growing demand for our products."
Marvin said demand is being stimulated by word of mouth from the first Inocucor Garden Solution customers in the southeast, including the famed Brookgreen Gardens, Clemson University's Sustainable Agriculture Program and a group of large vegetable crop field and greenhouses in the Carolinas.
Donald R. Marvin, ...
inocucor.com, 2 Feb 2015 [cached]
Donald R. Marvin, M.B.A.President and Chief Executive Officer & Director
Mr. Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years.
Prior to joining Inocucor Technologies, he was the president and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Most recently, Mr. Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
Previously, Mr. Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Mr. Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey's CFO of the year, he has raised over $300 million in both private and public financings and completed nearly a dozen M&A transactions for his former companies. Mr. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.
...
Mr. Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years.
Prior to joining Inocucor Technologies, he was the president and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Most recently, Mr. Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
Previously, Mr. Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Mr. Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey's CFO of the year, he has raised over $300 million in both private and public financings and completed nearly a dozen M&A transactions for his former companies. Mr. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.
Board of Directors | Microbiome Therapeutics
www.mbiome.com, 25 Sept 2014 [cached]
Donald R. Marvin, M.B.A. - Director
Independent Director Donald Marvin has over 25 years of leadership experience in the development and commercialization of novel diagnostic and research products. He is President and CEO of Cairn Associates, a life sciences strategy consulting and investment firm. Previously, Mr. Marvin was President and CEO of IdentiGEN, a leading provider of DNA-based solutions in the agriculture and food industries. He was a co-founder, CFO and Senior Vice President of Corporate Development of Orchid BioSciences, a pioneer in human DNA identity testing. Prior to Orchid, Mr. Marvin was President and CEO of Diatron Corp., a developer of fluorescence-based clinical diagnostic systems. Earlier in his career, he held positions in strategic planning, business development, operations and marketing at PepsiCo, Abbott Laboratories, Bayer and Boehringer Ingelheim. Mr. Marvin also serves as a Director of Melior Discovery. He received a B.S. degree from Ohio State University and an M.B.A. from Iona College.
Cairn Associates, Inc.
www.cairnassociates.com, 17 Sept 2013 [cached]
Donald Marvin, president and CEO of Cairn Associates, said, “We are pleased to have worked with the Validus Ventures team during the sale process. Validus’s strong management team and leading market position highly complement Where Food Comes From’s third-party identification, verification and traceability solutions for the food industry.â€
...
Founded in 1995, Cairn Associates emerged from the rich and extensive history of its founder, Donald Marvin, who has over 30 years of experience as a senior executive in start-up and expansion situations in small, high growth and Fortune 50 companies.
Donald R. ...
www.nbafinkansas.org, 16 Jan 2008 [cached]
Donald R. Marvin
President and CEOIdentiGEN North America, Inc.
Donald Marvin has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 25 years.Before joining IdentiGEN, he was the president and CEO of Cairn Associates, Inc., a life sciences strategy consulting and investment firm.He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.Previously, Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.His prior experience includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Marvin, named New Jersey's CFO of the Year 2001, is an experienced fund-raiser, having completed private and public financings that have raised over $250 million for his companies.He currently serves on the Board of Directors of Tepnel Life Sciences PLC and Melior Discovery, Inc.He received his B.S. degree from Ohio State University and his M.B.A. from Iona College.
Marvin currently lives in the greater Princeton, N.J., area with his wife, Kristine, and is in the process of relocating to the High Plains region.He participates in several angel investment groups and is the co-founder and former co-host of VentureTalkTM Radio, a show designed to bring together entrepreneurs, sources of capital and service providers.
Other People with the name "Marvin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304